However, even before the development of fourth-generation immunoassays like SIMOA, some previous studies have also evaluated NfL peripheral levels by ELISA in SZ (29, 30), BD (29, 31) and MDD (24, 31–35). This evidence concerns the gene NEFL and Behcet disease.